Changes
On July 25, 2022 at 11:49:25 AM UTC, Chimwemwe Mkandawire:
-
No fields were updated. See the metadata diff for more details.
f | 1 | { | f | 1 | { |
2 | "author": "", | 2 | "author": "", | ||
3 | "author_email": "cmkandawire@hivmw.org", | 3 | "author_email": "cmkandawire@hivmw.org", | ||
4 | "creator_user_id": "c64e3919-2d1c-42bf-835b-e85a6be9792c", | 4 | "creator_user_id": "c64e3919-2d1c-42bf-835b-e85a6be9792c", | ||
n | 5 | "groups": [], | n | 5 | "groups": [ |
6 | { | ||||
7 | "description": "Group for publications", | ||||
8 | "display_name": "Publication", | ||||
9 | "id": "816c3c41-f871-427d-9e26-fb21e6b3c578", | ||||
10 | "image_display_url": | ||||
11 | mw/uploads/group/2022-03-17-123757.433896243660articlesquareicon.png", | ||||
12 | "name": "publication", | ||||
13 | "title": "Publication" | ||||
14 | } | ||||
15 | ], | ||||
6 | "id": "e102b799-dfa8-473c-afa6-08d21fe80556", | 16 | "id": "e102b799-dfa8-473c-afa6-08d21fe80556", | ||
7 | "isopen": false, | 17 | "isopen": false, | ||
8 | "license_id": "notspecified", | 18 | "license_id": "notspecified", | ||
9 | "license_title": "License not specified", | 19 | "license_title": "License not specified", | ||
10 | "maintainer": null, | 20 | "maintainer": null, | ||
11 | "maintainer_email": null, | 21 | "maintainer_email": null, | ||
12 | "metadata_created": "2022-07-25T11:41:13.498786", | 22 | "metadata_created": "2022-07-25T11:41:13.498786", | ||
t | 13 | "metadata_modified": "2022-07-25T11:45:04.023695", | t | 23 | "metadata_modified": "2022-07-25T11:49:25.755390", |
14 | "name": "malawi-integrated-hiv-program-report-2019-q3", | 24 | "name": "malawi-integrated-hiv-program-report-2019-q3", | ||
15 | "notes": "* Scale-up of integrated HIV services had reached the | 25 | "notes": "* Scale-up of integrated HIV services had reached the | ||
16 | following number of sites:\r\n * __759__ static and __197__ | 26 | following number of sites:\r\n * __759__ static and __197__ | ||
17 | outreach HIV testing sites\r\n * __750__ (static) ART sites; | 27 | outreach HIV testing sites\r\n * __750__ (static) ART sites; | ||
18 | __615__ of these started at least one pregnant or breastfeeding woman | 28 | __615__ of these started at least one pregnant or breastfeeding woman | ||
19 | and 732 started asymptomatic patients (Test & Treat) this quarter\r\n | 29 | and 732 started asymptomatic patients (Test & Treat) this quarter\r\n | ||
20 | * __691__ sites with HIV-exposed children in follow-up \r\n* | 30 | * __691__ sites with HIV-exposed children in follow-up \r\n* | ||
21 | __1,019,610__ persons were tested for HIV and received their results; | 31 | __1,019,610__ persons were tested for HIV and received their results; | ||
22 | __207,831 (20%)__ accessed HIV testing for the first time; __811,779 | 32 | __207,831 (20%)__ accessed HIV testing for the first time; __811,779 | ||
23 | (80%)__ were repeat testers and __32,190 (4%)__ of these received | 33 | (80%)__ were repeat testers and __32,190 (4%)__ of these received | ||
24 | confirmatory testing (after having tested positive in the past). | 34 | confirmatory testing (after having tested positive in the past). | ||
25 | __28,376 (2.8%)__ clients received a positive result for the first | 35 | __28,376 (2.8%)__ clients received a positive result for the first | ||
26 | time.\r\n* A total of __30,622__ people received __38,444__ self-test | 36 | time.\r\n* A total of __30,622__ people received __38,444__ self-test | ||
27 | kits for either primary or secondary use.\r\n* __14,482 (80%)__ of | 37 | kits for either primary or secondary use.\r\n* __14,482 (80%)__ of | ||
28 | 18,018 blood units collected were screened for (at least) HIV, | 38 | 18,018 blood units collected were screened for (at least) HIV, | ||
29 | hepatitis B and syphilis\r\n* __168,033 (98%)__ of 172,271 women at | 39 | hepatitis B and syphilis\r\n* __168,033 (98%)__ of 172,271 women at | ||
30 | ANC had their HIV status ascertained; __11,669 (7%)__ of these were | 40 | ANC had their HIV status ascertained; __11,669 (7%)__ of these were | ||
31 | HIV positive. __149,107 (96%)__ of 155,842 at maternity had their HIV | 41 | HIV positive. __149,107 (96%)__ of 155,842 at maternity had their HIV | ||
32 | status ascertained __10,904 (7%)__ of these were HIV positive.\r\n* | 42 | status ascertained __10,904 (7%)__ of these were HIV positive.\r\n* | ||
33 | __27,624__ patients started ART this quarter; __80%__ were classified | 43 | __27,624__ patients started ART this quarter; __80%__ were classified | ||
34 | as asymptomatic / in WHO stage 1 and started under the \u201cTest & | 44 | as asymptomatic / in WHO stage 1 and started under the \u201cTest & | ||
35 | Treat\u201d policy.\r\n* __826,102__ patients were alive and on ART by | 45 | Treat\u201d policy.\r\n* __826,102__ patients were alive and on ART by | ||
36 | end of September 2019. This means that __77%__ of the estimated | 46 | end of September 2019. This means that __77%__ of the estimated | ||
37 | 1,070,896 HIV positive population were on ART. ART coverage was | 47 | 1,070,896 HIV positive population were on ART. ART coverage was | ||
38 | __69%__ (46,628/ 67,465) for children and __77%__ (779,474 / | 48 | __69%__ (46,628/ 67,465) for children and __77%__ (779,474 / | ||
39 | 1,003,432) for adults.\r\n* __125,766 (93%)__ of viral load results | 49 | 1,003,432) for adults.\r\n* __125,766 (93%)__ of viral load results | ||
40 | from routine monitoring were <1000 copies/ml. Viral suppression rates | 50 | from routine monitoring were <1000 copies/ml. Viral suppression rates | ||
41 | for routine samples among children (0-14 years) and adults (15+ years) | 51 | for routine samples among children (0-14 years) and adults (15+ years) | ||
42 | were __64%__ and __92%__, respectively.\r\n* __72%__ of adults and | 52 | were __64%__ and __92%__, respectively.\r\n* __72%__ of adults and | ||
43 | __75%__ of children were retained alive on ART at 12 months after | 53 | __75%__ of children were retained alive on ART at 12 months after | ||
44 | initiation.\r\n* Out of __796,167__ patients on first line adult ART | 54 | initiation.\r\n* Out of __796,167__ patients on first line adult ART | ||
45 | __286,394 (37%)__ were on TDF/3TC/EFV and __468,880 (60%)__ had | 55 | __286,394 (37%)__ were on TDF/3TC/EFV and __468,880 (60%)__ had | ||
46 | transitioned to TDF/3TC/DTG.\r\n* __13,114 6 (>99%)__ of an estimated | 56 | transitioned to TDF/3TC/DTG.\r\n* __13,114 6 (>99%)__ of an estimated | ||
47 | 10,932 3 HIV infected pregnant women in Malawi were on ART this | 57 | 10,932 3 HIV infected pregnant women in Malawi were on ART this | ||
48 | quarter. __9,521(73%)__ of these were already on ART when getting | 58 | quarter. __9,521(73%)__ of these were already on ART when getting | ||
49 | pregnant and __3,593 (27%)__ started ART during pregnancy/delivery.", | 59 | pregnant and __3,593 (27%)__ started ART during pregnancy/delivery.", | ||
50 | "num_resources": 1, | 60 | "num_resources": 1, | ||
51 | "num_tags": 9, | 61 | "num_tags": 9, | ||
52 | "organization": { | 62 | "organization": { | ||
53 | "approval_status": "approved", | 63 | "approval_status": "approved", | ||
54 | "created": "2021-10-14T11:02:35.234558", | 64 | "created": "2021-10-14T11:02:35.234558", | ||
55 | "description": "The Department of HIV & AIDS (DHA) was established | 65 | "description": "The Department of HIV & AIDS (DHA) was established | ||
56 | in 2001, initially as a unit in the Department of Clinical Services, | 66 | in 2001, initially as a unit in the Department of Clinical Services, | ||
57 | to coordinate the biomedical HIV Program in Malawi. The department now | 67 | to coordinate the biomedical HIV Program in Malawi. The department now | ||
58 | carries responsibility for various HIV related programs including: | 68 | carries responsibility for various HIV related programs including: | ||
59 | sexually transmitted infections (STIs), prevention of mother to child | 69 | sexually transmitted infections (STIs), prevention of mother to child | ||
60 | transmission of HIV (PMTCT), and national voluntary male medical | 70 | transmission of HIV (PMTCT), and national voluntary male medical | ||
61 | circumcision program (VMMC). All these HIV program sub-sections are | 71 | circumcision program (VMMC). All these HIV program sub-sections are | ||
62 | linked to one robust monitoring and evaluation sub-section in the HIV | 72 | linked to one robust monitoring and evaluation sub-section in the HIV | ||
63 | and AIDS Department which technically operates under the Central | 73 | and AIDS Department which technically operates under the Central | ||
64 | Monitoring and Evaluation Department (CMED) of the Ministry of | 74 | Monitoring and Evaluation Department (CMED) of the Ministry of | ||
65 | Health.", | 75 | Health.", | ||
66 | "id": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | 76 | "id": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | ||
67 | "image_url": | 77 | "image_url": | ||
68 | 2022-04-18-074318.527302WhatsApp-Image-2022-04-18-at-9.42.07-AM.jpeg", | 78 | 2022-04-18-074318.527302WhatsApp-Image-2022-04-18-at-9.42.07-AM.jpeg", | ||
69 | "is_organization": true, | 79 | "is_organization": true, | ||
70 | "name": "dha", | 80 | "name": "dha", | ||
71 | "state": "active", | 81 | "state": "active", | ||
72 | "title": "Department of HIV & AIDS and Viral Hepatitis", | 82 | "title": "Department of HIV & AIDS and Viral Hepatitis", | ||
73 | "type": "organization" | 83 | "type": "organization" | ||
74 | }, | 84 | }, | ||
75 | "owner_org": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | 85 | "owner_org": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | ||
76 | "private": false, | 86 | "private": false, | ||
77 | "program_area": "Care and Treatment", | 87 | "program_area": "Care and Treatment", | ||
78 | "relationships_as_object": [], | 88 | "relationships_as_object": [], | ||
79 | "relationships_as_subject": [], | 89 | "relationships_as_subject": [], | ||
80 | "resources": [ | 90 | "resources": [ | ||
81 | { | 91 | { | ||
82 | "cache_last_updated": null, | 92 | "cache_last_updated": null, | ||
83 | "cache_url": null, | 93 | "cache_url": null, | ||
84 | "created": "2022-07-25T11:43:22.154974", | 94 | "created": "2022-07-25T11:43:22.154974", | ||
85 | "description": "Integrated HIV Program Report July-September | 95 | "description": "Integrated HIV Program Report July-September | ||
86 | 2019", | 96 | 2019", | ||
87 | "format": "PDF", | 97 | "format": "PDF", | ||
88 | "hash": "", | 98 | "hash": "", | ||
89 | "id": "c0661901-df63-4622-8313-31e9cbc2c35c", | 99 | "id": "c0661901-df63-4622-8313-31e9cbc2c35c", | ||
90 | "last_modified": "2022-07-25T11:43:22.115050", | 100 | "last_modified": "2022-07-25T11:43:22.115050", | ||
91 | "lfs_prefix": | 101 | "lfs_prefix": | ||
92 | "dha/malawi-integrated-hiv-program-report-2019-q3", | 102 | "dha/malawi-integrated-hiv-program-report-2019-q3", | ||
93 | "metadata_modified": "2022-07-25T11:43:22.368287", | 103 | "metadata_modified": "2022-07-25T11:43:22.368287", | ||
94 | "mimetype": "application/pdf", | 104 | "mimetype": "application/pdf", | ||
95 | "mimetype_inner": null, | 105 | "mimetype_inner": null, | ||
96 | "name": "Malawi Integrated HIV Program Report 2019 Q3", | 106 | "name": "Malawi Integrated HIV Program Report 2019 Q3", | ||
97 | "package_id": "e102b799-dfa8-473c-afa6-08d21fe80556", | 107 | "package_id": "e102b799-dfa8-473c-afa6-08d21fe80556", | ||
98 | "position": 0, | 108 | "position": 0, | ||
99 | "resource_type": null, | 109 | "resource_type": null, | ||
100 | "sha256": | 110 | "sha256": | ||
101 | "3fc1d001d80cf10f75eaf41088b60ace09e8cf25621f67e654a117287ecfef67", | 111 | "3fc1d001d80cf10f75eaf41088b60ace09e8cf25621f67e654a117287ecfef67", | ||
102 | "size": 4297293, | 112 | "size": 4297293, | ||
103 | "state": "active", | 113 | "state": "active", | ||
104 | "url": | 114 | "url": | ||
105 | e9cbc2c35c/download/malawi_integrated_hiv_program_report_2019-q3.pdf", | 115 | e9cbc2c35c/download/malawi_integrated_hiv_program_report_2019-q3.pdf", | ||
106 | "url_type": "upload" | 116 | "url_type": "upload" | ||
107 | } | 117 | } | ||
108 | ], | 118 | ], | ||
109 | "state": "active", | 119 | "state": "active", | ||
110 | "tags": [ | 120 | "tags": [ | ||
111 | { | 121 | { | ||
112 | "display_name": "anc", | 122 | "display_name": "anc", | ||
113 | "id": "1e47aae6-8e3d-41e7-9b1a-778af0d2f23a", | 123 | "id": "1e47aae6-8e3d-41e7-9b1a-778af0d2f23a", | ||
114 | "name": "anc", | 124 | "name": "anc", | ||
115 | "state": "active", | 125 | "state": "active", | ||
116 | "vocabulary_id": null | 126 | "vocabulary_id": null | ||
117 | }, | 127 | }, | ||
118 | { | 128 | { | ||
119 | "display_name": "art", | 129 | "display_name": "art", | ||
120 | "id": "ab255b9d-6d35-4789-8ce0-ce10bbe1e299", | 130 | "id": "ab255b9d-6d35-4789-8ce0-ce10bbe1e299", | ||
121 | "name": "art", | 131 | "name": "art", | ||
122 | "state": "active", | 132 | "state": "active", | ||
123 | "vocabulary_id": null | 133 | "vocabulary_id": null | ||
124 | }, | 134 | }, | ||
125 | { | 135 | { | ||
126 | "display_name": "hiv", | 136 | "display_name": "hiv", | ||
127 | "id": "43013fde-ebf4-470e-9e5d-1a3aa939d404", | 137 | "id": "43013fde-ebf4-470e-9e5d-1a3aa939d404", | ||
128 | "name": "hiv", | 138 | "name": "hiv", | ||
129 | "state": "active", | 139 | "state": "active", | ||
130 | "vocabulary_id": null | 140 | "vocabulary_id": null | ||
131 | }, | 141 | }, | ||
132 | { | 142 | { | ||
133 | "display_name": "htc", | 143 | "display_name": "htc", | ||
134 | "id": "3aafcd8e-f836-4e61-9341-8e298f9d1f3a", | 144 | "id": "3aafcd8e-f836-4e61-9341-8e298f9d1f3a", | ||
135 | "name": "htc", | 145 | "name": "htc", | ||
136 | "state": "active", | 146 | "state": "active", | ||
137 | "vocabulary_id": null | 147 | "vocabulary_id": null | ||
138 | }, | 148 | }, | ||
139 | { | 149 | { | ||
140 | "display_name": "maternity", | 150 | "display_name": "maternity", | ||
141 | "id": "cd2b6dc5-5d1f-4a03-91da-9a279e193ed2", | 151 | "id": "cd2b6dc5-5d1f-4a03-91da-9a279e193ed2", | ||
142 | "name": "maternity", | 152 | "name": "maternity", | ||
143 | "state": "active", | 153 | "state": "active", | ||
144 | "vocabulary_id": null | 154 | "vocabulary_id": null | ||
145 | }, | 155 | }, | ||
146 | { | 156 | { | ||
147 | "display_name": "pmtct", | 157 | "display_name": "pmtct", | ||
148 | "id": "06c11980-f1fe-470d-8791-aeee38a117d5", | 158 | "id": "06c11980-f1fe-470d-8791-aeee38a117d5", | ||
149 | "name": "pmtct", | 159 | "name": "pmtct", | ||
150 | "state": "active", | 160 | "state": "active", | ||
151 | "vocabulary_id": null | 161 | "vocabulary_id": null | ||
152 | }, | 162 | }, | ||
153 | { | 163 | { | ||
154 | "display_name": "report", | 164 | "display_name": "report", | ||
155 | "id": "80c23033-8ff3-483d-8aa6-03e39b117372", | 165 | "id": "80c23033-8ff3-483d-8aa6-03e39b117372", | ||
156 | "name": "report", | 166 | "name": "report", | ||
157 | "state": "active", | 167 | "state": "active", | ||
158 | "vocabulary_id": null | 168 | "vocabulary_id": null | ||
159 | }, | 169 | }, | ||
160 | { | 170 | { | ||
161 | "display_name": "sti", | 171 | "display_name": "sti", | ||
162 | "id": "38222aa3-73ca-4ca8-8b42-9a5eb558af5a", | 172 | "id": "38222aa3-73ca-4ca8-8b42-9a5eb558af5a", | ||
163 | "name": "sti", | 173 | "name": "sti", | ||
164 | "state": "active", | 174 | "state": "active", | ||
165 | "vocabulary_id": null | 175 | "vocabulary_id": null | ||
166 | }, | 176 | }, | ||
167 | { | 177 | { | ||
168 | "display_name": "viral load", | 178 | "display_name": "viral load", | ||
169 | "id": "e385a0a4-1722-431f-a657-f9616a14bf6f", | 179 | "id": "e385a0a4-1722-431f-a657-f9616a14bf6f", | ||
170 | "name": "viral load", | 180 | "name": "viral load", | ||
171 | "state": "active", | 181 | "state": "active", | ||
172 | "vocabulary_id": null | 182 | "vocabulary_id": null | ||
173 | } | 183 | } | ||
174 | ], | 184 | ], | ||
175 | "title": "Malawi Integrated HIV Program Report 2019 Q3", | 185 | "title": "Malawi Integrated HIV Program Report 2019 Q3", | ||
176 | "type": "dataset", | 186 | "type": "dataset", | ||
177 | "url": null, | 187 | "url": null, | ||
178 | "version": null, | 188 | "version": null, | ||
179 | "year": "2019" | 189 | "year": "2019" | ||
180 | } | 190 | } |